Table 1. Characteristics of the two cohorts of patients with HGSOC.
A: RT/PCR cohort | |
---|---|
Median age at diagnosis (range), years | 58.5 (25-71) |
PTPN13 median expression (range) | 1.55 (0.066-14.03) |
FIGO stage n (%) | |
1-2 | 6 (22.2) |
3-4 | 21 (77.78) |
Cytoreductive surgery n (%) | |
Optimal | 11 (39.29) |
Suboptimal | 17 (60.71) |
Recurrence n (%) | |
NO | 8 (28.75) |
YES | 20 (71.43) |
Death n (%) | |
NO | 9 (32.14) |
YES | 19 (67.86) |
B: IHC cohort | |
Median age at diagnosis (range), years | 59 (34-85) |
PTPN13 n (%) | |
IRS | 14 (46.67) |
IRS ≥median (IRS=8) | 16 (53.33) |
FIGO stage n (%) | |
1-2 | 5 (16.67) |
3-4 | 25 (83.33) |
Recurrence n (%) | |
NO | 6 (20) |
YES | 24 (80) |
Death n (%) | |
NO | 4 (13.33) |
YES | 26 (86.67) |